Ondine Biomedical - Notification of major holdings - Pentwater

Ondine Biomedical

05/05/2026 17:02

RNS Number : 1185D

Ondine Biomedical Inc.

05 May 2026

 

Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS
1a. Identity of the issuer or the underlying issuer of existing shares:
Ondine Biomedical Inc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
X
2. Reason for the notification(please mark the appropriate box or boxes with an "X")
An acquisition or disposal of shares
An acquisition or disposal of financial instruments
X
An event changing the breakdown of shares outstanding
X
Other (please specify):
3. Details of person subject to the notification obligation
Name
Pentwater Capital Management LP
City and country of registered office (if applicable)
Naples,United States
4. Full name of shareholder(s)(if different from 3.)
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached:
05/05/2026
6. Date on which issuer notified (DD/MM/YYYY):
05/05/2026
7. Total positions of person(s) subject to the notification obligation
% of shares outstanding (total of 8. A)
% ofshares outstanding throughfinancial instruments
 (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of shares outstanding held in issuer
Resulting situation on the date on which threshold was crossed or reached
4.053088%
4.053088%
22,746,666.00
Position of previous notification (if
applicable)
3.993187%
3.993187%


 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedv
A: Shares
Class/type of
 shares
ISIN code (if possible)
Number of shares outstanding
% of shares outstanding
Direct
Indirect
Direct
Indirect
SUBTOTAL 8. A


 

 

B 1: Financial Instruments as an entitlement to acquire
Type of financial instrument
Expiration
 date
Exercise/
 Conversion Period
Number shares that may be acquired if the instrument is
exercised/converted.
% of shares outstanding
SUBTOTAL 8. B 1


 

 

B 2: Financial Instruments with similar economic effect
Type of financial instrument
Expiration
 date
Exercise/
 Conversion Period
Physical or cash
settlement
Number of shares
% of shares outstanding
Swap
Cash Settlement
22,746,666.00
4.053088%
SUBTOTAL 8.B.2
22,746,666.00
4.053088%

 

 

 

 

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation(please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer
Fullchain of controlled undertakings through which the shares and/or the
 financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(please add additional rows as necessary)
X
Name
% of shares outstanding if it equals or is higher than the notifiable threshold
% of shares outstanding through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
Matthew Halbower
MCH PWCM Holdings Inc.
Pentwater Capital Management LP
4.053088%
4.053088%
10. Additional information


 

Place of completion
Naples
Date of completion
05/05/2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
HOLEAKSSEEEKEFA